A detailed history of State Street Corp transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,175,353 shares of ITOS stock, worth $8.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,175,353
Previous 963,901 21.94%
Holding current value
$8.78 Million
Previous $14.3 Million 16.11%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.09 - $17.97 $2.13 Million - $3.8 Million
211,452 Added 21.94%
1,175,353 $12 Million
Q2 2024

Aug 14, 2024

BUY
$10.33 - $18.09 $3.99 Million - $6.99 Million
386,356 Added 66.9%
963,901 $14.3 Million
Q1 2024

May 15, 2024

BUY
$9.89 - $13.64 $257,041 - $354,503
25,990 Added 4.71%
577,545 $7.88 Million
Q4 2023

Feb 14, 2024

SELL
$8.57 - $11.06 $8.83 Million - $11.4 Million
-1,029,938 Reduced 65.12%
551,555 $6.04 Million
Q3 2023

Nov 14, 2023

BUY
$10.95 - $14.6 $178,386 - $237,848
16,291 Added 1.04%
1,581,493 $17.3 Million
Q2 2023

Aug 14, 2023

SELL
$12.93 - $18.05 $3.39 Million - $4.73 Million
-262,189 Reduced 14.35%
1,565,202 $20.7 Million
Q1 2023

May 15, 2023

BUY
$13.02 - $22.62 $1.17 Million - $2.04 Million
90,101 Added 5.19%
1,827,391 $24.9 Million
Q4 2022

Feb 14, 2023

SELL
$17.77 - $21.6 $6.59 Million - $8 Million
-370,578 Reduced 17.58%
1,737,290 $33.9 Million
Q3 2022

Nov 15, 2022

SELL
$18.6 - $27.25 $6.89 Million - $10.1 Million
-370,464 Reduced 14.95%
2,107,868 $40.2 Million
Q2 2022

Aug 15, 2022

BUY
$16.57 - $35.1 $12.7 Million - $26.9 Million
766,441 Added 44.77%
2,478,332 $51.1 Million
Q1 2022

May 16, 2022

BUY
$31.92 - $47.45 $30.3 Million - $45 Million
948,540 Added 124.26%
1,711,891 $55.1 Million
Q4 2021

Feb 14, 2022

BUY
$26.23 - $47.86 $11.6 Million - $21.1 Million
441,244 Added 136.99%
763,351 $35.5 Million
Q3 2021

Nov 15, 2021

BUY
$23.91 - $29.58 $94,157 - $116,486
3,938 Added 1.24%
322,107 $8.7 Million
Q2 2021

Aug 16, 2021

SELL
$17.9 - $36.1 $6.89 Million - $13.9 Million
-384,841 Reduced 54.74%
318,169 $8.16 Million
Q1 2021

May 17, 2021

BUY
$30.86 - $44.2 $15.9 Million - $22.7 Million
514,008 Added 271.96%
703,010 $24 Million
Q4 2020

Feb 16, 2021

BUY
$21.59 - $33.95 $1.25 Million - $1.96 Million
57,773 Added 44.02%
189,002 $6.39 Million
Q3 2020

Nov 10, 2020

BUY
$17.57 - $32.92 $2.31 Million - $4.32 Million
131,229 New
131,229 $3.24 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $266M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.